(Q34232680)

31 July 2017

1 reference

title

The extracellular matrix in multiple sclerosis: an update (English)

1 reference

31 July 2017

0 references

0 references

R A Sobel

1

1 reference

PubMed ID

11323746

31 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Brazilian Journal of Medical and Biological Research

31 July 2017

1 reference

31 July 2017

34

1 reference

31 July 2017

603-609

1 reference

31 July 2017

5

1 reference

The extracellular matrix in multiple sclerosis lesions.

31 July 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

B cells and antibodies in the pathogenesis of myelin injury in Semliki Forest Virus encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Constitutive alpha V beta 3 integrin-mediated adhesion of human lymphoid B cells to vitronectin substrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Antibodies to chondroitin sulfates A, B, and C: clinico-pathological correlates in neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Endothelial cell integrin laminin receptor expression in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Matrix metalloproteinases and diseases of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Extracellular matrix degradation by metalloproteinases and central nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Matrix metalloproteinases in inflammatory demyelination: targets for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Understanding the molecular basis of cell migration; implications for clinical therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Expression of extracellular matrix degrading enzymes during migration of xenografted brain cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Axonal pathology in multiple sclerosis. A historical note.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Axonal damage in acute multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Axonal pathology in multiple sclerosis: relationship to neurologic disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Nervous system proteoglycans as modulators of neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

Basal membrane-depleted scar in lesioned CNS: characteristics and relationships with regenerating axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000500007

10.1590/S0100-879X2001000500007

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11323746